Issue 3/2020
Content (26 Articles)
The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis
Micaela Almeida, Mafalda Soares, Ana Cristina Ramalhinho, José Fonseca Moutinho, Luiza Breitenfeld, Luísa Pereira
Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
Yan Li, Yidong Zhou, Feng Mao, Yan Lin, Xiaohui Zhang, Songjie Shen, Qiang Sun
HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies
Natasha Tracey, Helen Creedon, Alain J. Kemp, Jayne Culley, Morwenna Muir, Teresa Klinowska, Valerie G. Brunton
Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer
Sasagu Kurozumi, Sami Alsaeed, Nnamdi Orah, Islam M. Miligy, Chitra Joseph, Abrar Aljohani, Michael S. Toss, Takaaki Fujii, Ken Shirabe, Andrew R. Green, Mohammed A. Aleskandarany, Emad A. Rakha
Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis
Satu Tiainen, Amro Masarwah, Sanna Oikari, Kirsi Rilla, Kirsi Hämäläinen, Mazen Sudah, Anna Sutela, Ritva Vanninen, Juho Ikonen, Raija Tammi, Markku Tammi, Päivi Auvinen
Paget’s disease of the nipple in a Her2-positive breast cancer xenograft model
Katherine Drews-Elger, Ana Cristina Sandoval-Leon, Ayse Burcu Ergonul, Anna M. Jegg, Carmen Gomez-Fernandez, Philip C. Miller, Dorraya El-Ashry, Marc E. Lippman
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer
Aileen I. Fernandez, Xue Geng, Krysta Chaldekas, Brent Harris, Anju Duttargi, V. Layne Berry, Deborah L. Berry, Akanksha Mahajan, Luciane R. Cavalli, Balázs Győrffy, Ming Tan, Rebecca B. Riggins
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients
Yifan Wu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie
Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously
Ling-Wei Hii, Felicia Fei-Lei Chung, Jaslyn Sian-Siu Soo, Boon Shing Tan, Chun-Wai Mai, Chee-Onn Leong
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties
Kelly Kyker-Snowman, Robert M. Hughes, Christopher L. Yankaskas, Karen Cravero, Swathi Karthikeyan, Berry Button, Ian Waters, David Marc Rosen, Lauren Dennison, Natasha Hunter, Josh Donaldson, Eric S. Christenson, Konstantinos Konstantopoulos, Paula J. Hurley, Sarah Croessmann, Ben Ho Park
Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer
Sabine Heublein, Markus Egger, Junyan Zhu, Luisa Berger, Doris Mayr, Christian Schindlbeck, Christina Kuhn, Simone S. Hofmann, Florian Schuetz, Udo Jeschke, Nina Ditsch
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice
David R. Meier, Megan A. Girtman, Kristopher A. Lofgren, Paraic A. Kenny
Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?
Laura H. Rosenberger, Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Oluwadamilola M. Fayanju, E. Shelley Hwang, Jennifer K. Plichta
Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions
Nicole Look Hong, Frances C. Wright, Mark Semple, Alexandru M. Nicolae, Ananth Ravi
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer
Anouk K. M. Claessens, Reinier Timman, Jan J. Busschbach, Jeanette M. Bouma, Jeany M. Rademaker-Lakhai, Frans L. G. Erdkamp, Vivianne C. G. Tjan-Heijnen, Monique E. M. M. Bos
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
Min Hwan Kim, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joohyuk Sohn
25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival
Charlotte Kanstrup, Dorthe Teilum, Lars Rejnmark, Janne Villemoes Bigaard, Pia Eiken, Niels Kroman, Anne Tjønneland, Mathias Kvist Mejdahl
Weight trajectories in women receiving systemic adjuvant therapy for breast cancer
Kirsten A. Nyrop, Allison M. Deal, Shlomit S. Shachar, Jihye Park, Seul Ki Choi, Jordan T. Lee, Erin A. O’Hare, Amy Wheless, Lisa A. Carey, Hyman B. Muss
Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information
A. Frisell, J. Lagergren, M. Halle, J. de Boniface
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39
Ekaterina S. Kuligina, Anna P. Sokolenko, Ilya V. Bizin, Alexandr A. Romanko, Kirill A. Zagorodnev, Maria O. Anisimova, Daria D. Krylova, Elena I. Anisimova, Maria A. Mantseva, Ashok K. Varma, Syed K. Hasan, Valeria I. Ni, Andrey V. Koloskov, Evgeny N. Suspitsin, Aigul R. Venina, Svetlana N. Aleksakhina, Tatiana N. Sokolova, Ana Marija Milanović, Peter Schürmann, Darya S. Prokofyeva, Marina A. Bermisheva, Elza K. Khusnutdinova, Natalia Bogdanova, Thilo Dörk, Evgeny N. Imyanitov
Pre- and post-diagnostic intake of whole grain and dairy products and breast cancer prognosis: the Danish Diet, Cancer and Health cohort
Julie Louise Munk Andersen, Louise Hansen, Birthe Lykke Riegels Thomsen, Lisa Rudolph Christiansen, Lars Ove Dragsted, Anja Olsen
Breast density measured volumetrically in a clinical environment: cross-sectional study with photon counting technology
Jean L. Browne, Lilian Casas, Guillermo Santandreu, Ignacio Rodriguez, Beatriz Navarro, Francesc Tresserra, M. Angela Pascual
Do multifocal or multicentric pT1a node-negative HER2+ breast cancers get benefit from systemic treatment?
Kadri Altundag
Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery?
Darko Zdravkovic, Miroslav Granic, Bogdan Crnokrak
Re: Association of depression and anxiety disorder with the risk of mortality in breast cancer
Hong-Lin Chen, Lin Du, Xiao-Min Li
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
Suzanne E. Wardell, Alexander P. Yllanes, Christina A. Chao, Yeeun Bae, Kaitlyn J. Andreano, Taylor K. Desautels, Kendall A. Heetderks, Jeremy T. Blitzer, John D. Norris, Donald P. McDonnell